Øivind Torkildsen

10PUBLICATIONS
35CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Environmental biogeochemistryPsychosocial aspects of childbirth and perinatal mental healthBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 15, 2026
CD4+ T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis.

|Jan 28, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosis.

Marcus Koch, Jop Mostert, Eva M Strijbis

|Nov 25, 2025
Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate.

Øivind Torkildsen, Alla N S Bru, Gry Inger Nerås Behzadi

|Aug 14, 2025
In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing-Remitting Multiple Sclerosis.

Shamundeeswari Anandan, Karina Maciak, Regina Breinbauer

|Feb 10, 2024
Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms.

Karine Eid, Marte-Helene Bjørk, Nils Erik Gilhus

|Jul 25, 2022
Safety of breast feeding during rituximab treatment in multiple sclerosis.

Brit Ellen Rød, Øivind Torkildsen, Kjell-Morten Myhr

Pageof 2

Frequent Collaborators

4 joint publications

Kjell-Morten Myhr

2 joint publications

Karine Eid

2 joint publications

Stig Wergeland

2 joint publications

Marte-Helene Bjørk